Can adult stem cells transform into any cell of the body

Can adult stem cells transform into any cell of the body? Yes, recent scientific studies have shown that adult stem cells can transform into virtually any type of cell in the body. For example adult stem cells came become brain cells, kidney cells, heart cells, muscle cells, etc.

 

Do Stemtech products contain stem cells?

Our products do not contain stem cells of any kind and are not associated with embryonic stem cells or treatments involving any kind of stem cells.

 

What do Stemtech products do?

Stemtech’s products support the natural release and activity of adult stem cells in the body.

 

What role do adult stem cells play in the body?

The US National Institutes of Health states that the role of adult stem cells in the body is that of tissue maintenance and repair.

 

What is the adult stem cell theory of renewal?

The Adult Stem Cell Theory of Renewal proposes that adult stem cells are naturally released by the bone marrow and travel through the bloodstream and into tissues to promote the body’s natural process of tissue renewal.

How does an increase in the number of circulating stem cells lead to optimal health

How does an increase in the number of circulating stem cells lead to optimal health?
Circulating stem cells can reach various organs and become cells of that organ, helping such organ regain and maintain optimal health. Recent studies have suggested that number of circulating stem cells is the key factor; the higher the number of circulating stem cells the greater is the ability of the body to heal itself.

STEM CELL SECRET CLICK HERE

StemEnhance ,improves muscle regeneration in cardiotoxin induced muscle injury

Mobilization of bone marrow stem cells with StemEnhance ,improves muscle regeneration in cardiotoxin induced muscle injury

It was shown that stem cells released from the bone marrow can migrate into
injured tissues, supporting the process of tissue repair. In this process, the number of circulating
stem cells was shown to be a critical factor. In a number of stud ies addressing various
health conditions, higher numbers of circulating stem cells have been associated with
greater health. An increase in the number of circulating stem cells was shown to improve various health conditions.

Based on this information, it was claimed that the natural stem cell mobilizer
StemEnhance had the ability to support optimal health by increasing the number of
circulating stem cells. StemEnhance is an extract from the aquatic botanical
Aphanizomenon flosaquae that was shown in a double blind crossover study to increase
the number of circulating stem cells by 25 - 30%. This study was aimed at con
firming the effect of StemEnhance™ on tissue repair.

Read More Here , http://74.115.92.38/public/us/science/MuscleInjuryStudy.pdf

More article ,

muscular dystrophy stem cell research

muscular dystrophy stem cell research, Early studies in the US successfully transplanted stem cells from healthy newborn mice into muscles of mice bred to simulate muscular dystrophy. These cells provide the missing protein and are fully incorporated into muscle tissue. 

This basic research contributed in part to the establishment in 2004 in Canada of the first clinical trial for the treatment of Duchenne muscular dystrophy. The results of this trial demonstrated that when muscle precursor cells (called "myoblasts") from a healthy donor are transplanted into the affected muscle of a patient with Duchenne muscular dystrophy they fuse with the host myofibers and donate their healthy genome, allowing the correct form of the gene to be expressed. It is now known that a small fraction of healthy nuclei can provide enough dystrophin to completely cure a myofiber and ensure its survival. 

The success of this cell transplantation protocol depends on suppressing the immune system with a new drug called Tacrolimus, on the injection of a high number of cells and on a short distance between the injection sites. In other words, the effects are localized to the site of cell injection. The limitation of this technique is that cells have to be injected into each muscle in turn, whereas muscular dystrophy affects the entire body. 

READ MORE

 

Increase in stem cells with the use of anti-inflammatory medication

Increase in stem cells with the use of anti-inflammatory medication,  Recent research from Indiana University School of Medicine shows a positive correlation between NSAIDs (Non-steroidal anti-inflammatory drugs) use and a boost in stem cells. Traditionally, NSAIDs are restricted prior to procedures such as Platelet-rich plasma (PRP) injection. However, this research suggests that a limited course of Meloxicam (NSAIDs) may increase stem cell count in PRP. Before this is recommended on a regular basis, more data is needed. -

 See more at: http://www.orthohealing.com/

Using stem cells to create key structures of the inner ear in mice

using stem cells to create key structures of the inner ear in mice,        The Indiana University researchers found that by using a 3D cell-culture method, they were able to persuade stem cells to develop into inner ear sensory epithelium, which detects head movement, gravity and sound. The epithelium contains hair cells, supporting cells and neurons.

A 3D cell-culture method can more closely copy natural tissues and organs than cells grown two-dimensionally. In 3D cell culture, cells can attach to each other and form natural cell-to-cell attachments.

READ MORE

List Journal of stem cell research

List Journal of stem cell research. Elsevier announced today that it is launching a new journal, Stem Cell Research, in September 2007. The journal will be published 6 times a year and will focus on high quality research in all aspects of stem cell science and applications.

Read More

List Journal of stem cell research, Here

 

University of Michigan stem cell research

University of Michigan stem cell research. The University of Michigan has recently emerged as a national leader in the three main types of stem cell research: embryonic, adult, and reprogrammed cells known as iPS cells. 

A long-time leader in the study of adult stem cells, U-M has bolstered its human embryonic stem cell program, and added a complementary iPS cell research effort, since the passage of Proposal 2 in November 2008. The state constitutional amendment eased onerous restrictions on the types of embryonic stem cell research allowed in Michigan.

Recent milestones include:

• The launch, in March 2009, of a U-M-led consortium to create new human embryonic stem cell lines to aid the search for disease treatments and cures. The A. Alfred Taubman Medical Research Institute’s Consortium for Stem Cell Therapies (CSCT) is based at the Medical School, and researchers from across campus—including scientists at the Life Sciences Institute, the College of Engineering, the Comprehensive Cancer Center and the Department of Cell and Developmental Biology—participate.
  
  In addition, collaborations are underway between CSCT and U-M’s University Research Corridor partners—Michigan State University and Wayne State University–as well and other institutions.
• CSCT’s development of the state’s first human embryonic stem cell line in October 2010. The first Michigan line, known as UM4-6, is the product of years of planning and preparation at U-M; the work was made possible by the state constitutional amendment allowing Michigan researchers to derive embryonic stem cell lines using surplus embryos from fertility clinics.
• CSCT’s development, in April 2011, of Michigan’s first human embryonic stem cell lines carrying the genes responsible for inherited diseases. With this accomplishment, U-M joined a small handful of U.S. universities that are producing disease-specific human embryonic stem cell lines. The work will enable scientists here and around the world to study the onset and progression of genetic disorders and to search for new treatments.
• The reprogramming, by CSCT scientists in July 2011, of adult skin cells so they behave like embryonic stem cells. The reprogrammed cells are called induced pluripotent stem cells, or iPS cells. They display many of the most scientifically valuable properties of embryonic stem cells while enabling researchers to bypass embryos altogether.
• The announcement on Feb. 14, 2012, that the U-M’s first human embryonic stem cell line, UM4-6, will be added to the National Institutes of Health’s national registry, joining 146 other cell lines. Inclusion on the national registry makes the U-M-derived cell line available to the scientific community for federally funded embryonic stem cell research projects. Registry listing was a prime CSCT goal since its inception.
• In January of 2013 the Consortium for Stem Cell Therapies reorganized with an enhanced focus on disease-specific stem cells and was re-named MStem Cell Laboratories. MStem Cell Laboratories have obtained generous funding from the University of Michigan President’s Office, Medical School Dean’s Office, A. Alfred Taubman Medical Research Institute, and Department of Obstetrics and Gynecology.

In addition to the work underway by the Consortium for Stem Cell Therapies, hubs for U-M stem cell research also exist at the Life Science Institute’s Center for Stem Cell Biology and at the U-M Health System’s Comprehensive Cancer Center. Other groundbreaking stem cell work is being pursued at other units across campus.

The Center for Stem Cell Biology was established in 2005 with $10.5 million provided by the U-M Medical School, the Life Sciences Institute, and the Molecular and Behavioral Neurosciences Institute.

The center’s main goal is to determine the fundamental mechanisms that regulate stem cell function. That knowledge, in turn, provides new insights into the origins of disease and suggests new approaches to disease treatment. Most of the work involves adult stem cells — including blood-forming and nervous system stem cells — but human embryonic stem cells also are studied.

http://www.stemcellresearch.umich.edu/